Submit RFI/RFP
Request Consultation
PV Requirements in Singapore: A Practical Guide
Pharmacovigilance (PV) is a critical component of the global healthcare ecosystem, ensuring that medicines remain safe and effective after they are approved and introduced into the market. In…
Tagged content
ADR
3 articles
Warnings Spain’s AEMPS Publishes December 2025 Safety Bulletin
Spanish Agency of Medicines and Medical Devices (AEMPS) has released its Drug Safety Bulletin for December 2025, summarizing updated pharmacovigilance information for medicines marketed in Spain. The bulletin…
Warnings Anticholinergic Burden & ADRs: Real-World French PV Data
A new study published in Drug Safety reveals significant limitations in commonly used anticholinergic burden (ACB) scales, showing they fail to fully capture real-world adverse drug reactions (ADRs)…
Ready to simplify your journey?
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP